CS logo
small CS logo
Queen Mary Hospital, Tung Wah Hospital

Hong Kong, Hong Kong
位於香港的醫院

About Queen Mary Hospital, Tung Wah Hospital


東華醫院位於香港香港島中西區太平山區普仁街12號,是由醫院管理局管理的公立醫院之一,乃港島西聯網僅次於瑪麗醫院的第二大醫院,同時亦為一間社區醫院,主要服務中西區居民。東華醫院現時除提供服務給來自瑪麗醫院的轉院病人外,更是一間半急症全科醫院。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Queen Mary Hospital, Tung Wah Hospital


During the past decade, Queen Mary Hospital, Tung Wah Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary Hospital, Tung Wah Hospital" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Queen Mary Hospital, Tung Wah Hospital


According to Clinical.Site data, the most researched conditions in "Queen Mary Hospital, Tung Wah Hospital" are "Endstage Renal Disease" (4 trials), "Secondary Hyperparathyroidism" (2 trials), "Diabetes" (1 trials), "End-stage Renal Disease" (1 trials) and "Kidney Failure" (1 trials). Many other conditions were trialed in "Queen Mary Hospital, Tung Wah Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Queen Mary Hospital, Tung Wah Hospital


Most popular intervention types in "Queen Mary Hospital, Tung Wah Hospital" are "Drug" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pioglitazone" (2 trials), "Cinacalcet" (1 trials), "Intravenous Paricalcitol" (1 trials), "Placebo comparator" (1 trials) and "Surgical total parathyroidectomy with forearm autografting" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Queen Mary Hospital, Tung Wah Hospital


The vast majority of trials in "Queen Mary Hospital, Tung Wah Hospital" are 6 trials for "All" genders.

Clinical Trials Status at Queen Mary Hospital, Tung Wah Hospital


Currently, there are NaN active trials in "Queen Mary Hospital, Tung Wah Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Queen Mary Hospital, Tung Wah Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Mary Hospital, Tung Wah Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".